
Apollo Therapeutics
Apollo Therapeutics is a portfolio biopharmaceutical company that develops new medicines.
$226.5M Series B+ ·
Source: fundraisingfox.com
Funding history ↓Signals
About Apollo Therapeutics
It translates breakthroughs in biology and basic medical research into novel therapeutics. The company identifies and advances pre-clinical and clinical-stage therapeutic programs.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $226.5M | — | fundraisingfox.com |
Timeline
- Website created
Companies like Apollo Therapeutics
SSagimet BiosciencesSeries B+ · Apr 2026LLifeMine Therapeutics$75M Series B+ · Aug 2026
IIDRx$120M Series B+ · Aug 2024
RR1 Therapeutics$80.5M Series A · Sep 2026
AAdjuvia Therapeutics$8M Seed · Jul 2026
335PharmaSeries B+ · Nov 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/apollo-therapeutics (get a free API key).